Pharma needs to be more upfront about FDA drug rejections

FDA researchers are calling for greater transparency from drug companies when their drug is rejected by the agency, according to a study in the British Medical Journal. » More from FDA’s Peter Lurie, MD

FDA, PatientsLikeMe partner on drug safety data

FDA and PatientsLikeMe will partner to determine how patient-reported data can give new insights into drug safety.
» How the collaboration will work

Continuing Education

MTM essentials for COPD management: Part 1

This month’s CE activity is part of a CPE series, Medication Therapy Management for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month’s activity is to assist pharmacists in understanding the pathophysiology and pharmacologic treatment of COPD and to discuss how COPD is similar to and different from other chronic respiratory disorders.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT31-KTJ28.

Announcement: The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. To review your registration page or to register, go to: https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

GLP-1 receptor better in reducing blood sugar compared to injectable therapy in Japanese patients

Once-weekly dulaglutide is an effective treatment option for patients with type 2 diabetes who need to advance to injectable therapy, according to results from a Japanese study presented at the 2015 American Diabetes Association Scientific Sessions.
» Study details

• FDA's Sentinel Initiative identifies drug safety problems

• Patient groups bothered over diminished safety standards for biosimilars

RESOURCES

Latest Clinical News

UBM MEDICA